NCT03109223View on ClinicalTrials.gov

Addition to Infant Formula of 2-fucosyllactose (2-FL)

NACompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

July 15, 2017

Primary Completion Date

May 17, 2021

Study Completion Date

May 17, 2021

Conditions
Growth of Infants
Interventions
OTHER

sole source nutrition

Infant formula

Trial Locations (6)

10468

Advantage Clinical Trials, The Bronx

22015

PI-Coor Clinical Research, LLC, Burke

35205

Alabama Clinical Therapeutics, LLC, Birmingham

47715

Qualmedica Research, LLC dba Pedia Research, LLC, Evansville

84107

JBR Clinical Research, Salt Lake City

Unknown

Hospital Clinica Bendana, San Pedro Sula

All Listed Sponsors
lead

PBM Nutritionals

INDUSTRY

NCT03109223 - Addition to Infant Formula of 2-fucosyllactose (2-FL) | Biotech Hunter | Biotech Hunter